Unraveling the neuroprotective effect of perampanel and lacosamide combination in the corneal kindling model for epilepsy in mice
Animal Models and Experimental Medicine · 2025
DOI: 10.1002/ame2.12524 ↗Kurz gefasst
Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, 2025. Verfasst von Saba Tehreem und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Pharmacy, Bahauddin Zakariya University, Multan, Pakistan. Hauptthemen laut MEDLINE: Lacosamide, Kindling, Neurologic, Pyridones, Epilepsy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Distinguished Scientist Fellowship program King Saud University, King Saud University.
Abstract (Originalsprache)
Background
Scientific evidence to guide clinicians on the use of different antiseizure drugs in combination therapy is either very limited or lacking. In this study, the impact of lacosamide and perampanel alone and in combination was tested in corneal kindling model in mice, which is a cost‐effective mechanism for screening of antiseizure drugs.
Methods
The impact of lacosamide (5 mg/kg) and perampanel (0.125 mg/kg) alone and their combination was tested in corneal kindling process (3‐mA current for 3 s applied twice daily for consecutive 12 days) in male BALB/c mice. Post‐kindling, mice were subjected to a battery of behavioral tests assessing anxiety, memory, and depression‐like behaviors. Brain tissues were then harvested for analysis of oxidative stress biomarkers.
Results
Our results showed that the combination therapy of lacosamide and perampanel was more effective in reducing seizure progression than monotherapy of these drugs. Animals treated with combination therapy showed significant behavioral improvements, as reduced anxiety and depression were noticed, and their cognitive abilities were notably better compared to animals of all other groups. Moreover, biochemical assays of isolated brains from combination‐treated group revealed lesser amount of oxidative stress. In addition, outcomes of dual regime were comparable to the phenytoin in seizure control but showed superior benefits in mitigation of kindling‐prompted behavioral dysfunction and oxidative stress.
Conclusions
This study suggests that the lacosamide and perampanel combination therapy worked noticeably better in halting the corneal kindling process in mice and improved the epilepsy‐associated psychiatric disorders that might be due to antioxidant effects of both drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Faculty of Pharmacy, Bahauddin Zakariya University, Multan, Pakistan.
- Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
- Institut pour l'Avancée des Biosciences, Centre de Recherche UGA/INSERM U1209/CNRS 5309, Université Grenoble Alpes, Grenoble, France.
ORCID-Profile: Waseem Ashraf, Imran Imran
Förderung
- Distinguished Scientist Fellowship program King Saud University
- King Saud University
Zitieren
APA
Tehreem, S., Sabir, A., Farooq, M., Ashraf, W., Alqahtani, F., Ahmad, T., & Imran, I. (2025). Unraveling the neuroprotective effect of perampanel and lacosamide combination in the corneal kindling model for epilepsy in mice. Animal Models and Experimental Medicine. https://doi.org/10.1002/ame2.12524
Vancouver
Tehreem S, Sabir A, Farooq M, Ashraf W, Alqahtani F, Ahmad T, et al. Unraveling the neuroprotective effect of perampanel and lacosamide combination in the corneal kindling model for epilepsy in mice. Animal Models and Experimental Medicine. 2025. doi:10.1002/ame2.12524
BibTeX
@article{Tehreem2025,
author = {Tehreem, Saba and Sabir, Azka and Farooq, Maryam and Ashraf, Waseem and Alqahtani, Faleh and Ahmad, Tanveer and Imran, Imran},
title = {Unraveling the neuroprotective effect of perampanel and lacosamide combination in the corneal kindling model for epilepsy in mice},
journal = {Animal Models and Experimental Medicine},
year = {2025},
doi = {10.1002/ame2.12524}
}
EUVIMED